BSX vs PATH
Boston Scientific Corp (BSX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the BSX and PATH stock pages for the full models.
Not investment advice.